kenvue: Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here’s background, current challenges, future outlook, market reaction
Kenvue stock share price today surged after Kimberly-Clark confirmed it would acquire Tylenol maker Kenvue in a deal worth about $40 billion. The merger will combine household brands such as Huggies, Kleenex, and Tylenol, forming one of the biggest consumer health product companies in the United States.
Kimberly-Clark to buy Kenvue for $40 billion
Kimberly-Clark announced it will buy Kenvue, the maker of Tylenol, for more than $40 billion in cash and stock. The deal values each Kenvue share at $21.01. The offer includes $3.50 in cash and 0.14625 shares of Kimberly-Clark stock for each Kenvue (KVUE) share. Based on the latest filings, the acquisition totals about $40.3 billion, with an enterprise value of $48.7 billion.
Shares of Kenvue…
